Disclosure of Authors' Conflicts of Interest: A Follow-up

Publisher Website
Google Scholar
Abstract
We noted in the November 18 issue1 that Dr. Vera Price, the author of a Drug Therapy article published in the September 23 issue,2 had received major research support through her university from companies that manufactured drugs discussed in her article and that she had recently consulted for those companies. Although she informed us of these arrangements at the time her article was solicited, we failed to respond in accordance with our conflict-of-interest policy, which would have disqualified her. Because of the inconsistency between our stated policy and practice in this case, we reviewed the files and spoke with the authors of the Drug Therapy articles published since January 1, 1997, to determine whether there were similar inconsistencies. We have now completed our review. We found 18 instances in which one or more authors of Drug Therapy articles received major research support through their institutions from relevant companies or served as consultants for those companies at the time they were invited to prepare their articles. The authors had informed us of these arrangements, and the editors in Boston were aware of them and approved them. The list is as follows:

This publication has 2 references indexed in Scilit: